ClinicalTrials.Veeva

Menu

Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent Vertebra

U

Ullevaal University Hospital

Status

Suspended

Conditions

Osteoporosis
Vertebral Fracture

Treatments

Procedure: Percutaneous vertebroplasty

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Percutaneous vertebroplasty is a treatment for painful osteoporotic compression fractures. Multiple reports have shown as high as 20 % refracturerates in vertebrae adjacent to those that have been treated with percutaneous vertebroplasty.

The purpose of the study is to determine if prophylactic vertebroplasty of unfractured vertebrae adjacent to the treated fractured vertebrae can reduce the rates of refracture in adjacent vertebrae.

Enrollment

100 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CT and MRI proven non healed painful osteoporotic compression fracture in the thoracic and lumbar spine.

Exclusion criteria

  • Infection
  • High grade spinal stenosis
  • Contraindications to MRI
  • Dementia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

1
Active Comparator group
Description:
50 osteoporotic patients with a vertebral insufficiency fracture will receive treatment of the vertebrae with standard vertebroplasty
Treatment:
Procedure: Percutaneous vertebroplasty
2
Experimental group
Description:
50 osteoporotic patients with a vertebral insufficiency fracture will receive treatment of the vertebrae with standard vertebroplasty. The adjacent vertebrae will be treated with 3-5 ml of PMMA
Treatment:
Procedure: Percutaneous vertebroplasty

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems